IL33 and multiple sclerosis: The histone deacetylase HDAC3 was shown to act as a transcriptional repressor of IL-33 in multiple sclerosis patients [57] and in a model of Staphylococcus aureus-aggravated skin inflammation associated to atopic dermatitis [58].